We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Sues Endo, Impax Over Alleged Antitrust Violations
FTC Sues Endo, Impax Over Alleged Antitrust Violations
The Federal Trade Commission (FTC) has filed a lawsuit against Endo Pharmaceuticals and Impax Laboratories alleging that a 2017 agreement between the companies violated the antitrust laws by eliminating competition in the market for an extended release opioid, oxymorphone ER.